An Anti-Ubiquitin Antibody Response in Transitional Cell Carcinoma of the Urinary Bladder

• Peter U. Ardelt ,

  * E-mail: Peter.Ardelt@usb.ch

  Affiliations Department of Urology, University Hospital Basel, Basel, Switzerland, Department of Urology and Pediatric Urology, Medical School, Albert-Ludwigs-University of Freiburg, Freiburg, Germany, Department of Urology, Bavarian Julius Maximilians-University Medical School, Würzburg, Germany

  ⨯
• Jan Ebbing,

  Affiliation Department of Urology, University Hospital Basel, Basel, Switzerland

  ⨯
• Fabian Adams,

  Affiliation Department of Urology and Pediatric Urology, Medical School, Albert-Ludwigs-University of Freiburg, Freiburg, Germany

  ⨯
• Cora Reiss,

  Affiliation Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center Mainz, Mainz, Germany

  ⨯
• Wadih Arap,

  Affiliation Division of Hematology/Oncology and Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America

  ⨯
• Renata Pasqualini,

  Affiliation Division of Hematology/Oncology and Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America

  ⨯
• Alexander Bachmann,

  Affiliation Department of Urology, University Hospital Basel, Basel, Switzerland

  ⨯
• Ulrich Wetterauer,

  Affiliation Department of Urology and Pediatric Urology, Medical School, Albert-Ludwigs-University of Freiburg, Freiburg, Germany

  ⨯
• Hubertus Riedmiller,

  Affiliation Department of Urology, Bavarian Julius Maximilians-University Medical School, Würzburg, Germany

  ⨯
• Burkhard Kneitz

  Affiliation Department of Urology, Bavarian Julius Maximilians-University Medical School, Würzburg, Germany

  ⨯